Cannabis finance news

Company news: Releaf Group; Elixinol Wellness

by Martin Lane October 15, 2021October 15, 2021

Releaf Group Releaf Group is launching licensed wholesale and distribution division Releaf Dispensaries on November 1 […]

Company news: Helius Therapeutics; ECS Botanics; Opticann; Releaf Group; Greenfern Industries

by Martin Lane October 12, 2021October 13, 2021

Company news: Incannex; Altum; Cannasouth; Roto-Gro; Avecho; Mernova; Medlab; Creso Pharma

by Martin Lane October 7, 2021October 7, 2021

Ora Pharm looks to raise NZ$11.5m on the Syndex Exchange

by Hannah Adler September 29, 2021September 29, 2021

Althea bets on dual strategy as CEO predicts big pharma will come knocking ‘sooner than we thought’

by Steve Jones September 23, 2021September 23, 2021

Fintech lender and accountancy firm team up to ‘increase financial literacy across the cannabis industry’

by Hannah Adler September 15, 2021September 15, 2021

Cronos Australia and CDA Health agree merger deal

by Hannah Adler September 14, 2021September 16, 2021

Report finds sales of three major cannabis pharmaceutical products set to reach EU$1.8 billion by 2025

by Hannah Adler September 6, 2021September 8, 2021

Roby Zomer

Company news: MGC Pharma; Emyria; ECS Botanics; Rua Bioscience; AusCann; Cannasouth; Cronos; Althea

by Martin Lane September 2, 2021September 2, 2021

ONJ Foundation

Cann Global deal to bring Olivia’s Choice cannabis formula to Australia hits regulatory buffers

by Steve Jones September 2, 2021September 2, 2021